Vanguard Personalized Indexing Management LLC boosted its position in shares of Xylem Inc. (NYSE:XYL – Free Report) by 19.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 56,216 shares of the industrial products company’s stock after purchasing an additional 8,960 shares during the quarter. Vanguard Personalized Indexing Management LLC’s holdings in Xylem were worth $8,292,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in shares of Xylem in the second quarter valued at about $338,232,000. ABN AMRO Bank N.V. bought a new stake in Xylem in the 2nd quarter valued at approximately $208,226,000. Swedbank AB boosted its position in Xylem by 19.0% during the 3rd quarter. Swedbank AB now owns 5,197,753 shares of the industrial products company’s stock worth $766,669,000 after acquiring an additional 830,821 shares during the last quarter. Amundi raised its holdings in shares of Xylem by 17.0% in the second quarter. Amundi now owns 5,714,576 shares of the industrial products company’s stock valued at $730,717,000 after purchasing an additional 830,337 shares during the last quarter. Finally, Voya Investment Management LLC lifted its position in shares of Xylem by 544.0% in the third quarter. Voya Investment Management LLC now owns 868,755 shares of the industrial products company’s stock worth $128,141,000 after purchasing an additional 733,860 shares in the last quarter. Institutional investors own 87.96% of the company’s stock.
Xylem Stock Up 1.5%
NYSE XYL opened at $143.38 on Tuesday. The business has a fifty day moving average price of $139.71 and a two-hundred day moving average price of $141.69. The stock has a market capitalization of $34.91 billion, a PE ratio of 36.86, a PEG ratio of 2.00 and a beta of 1.17. Xylem Inc. has a fifty-two week low of $100.47 and a fifty-two week high of $154.27. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.50.
Xylem Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Shareholders of record on Tuesday, November 25th were paid a dividend of $0.40 per share. The ex-dividend date of this dividend was Tuesday, November 25th. This represents a $1.60 annualized dividend and a yield of 1.1%. Xylem’s payout ratio is presently 41.13%.
Insider Activity at Xylem
In other news, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction on Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the transaction, the director directly owned 16,875 shares in the company, valued at approximately $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Claudia S. Toussaint sold 10,421 shares of the business’s stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the sale, the executive vice president owned 31,250 shares in the company, valued at $4,770,000. This represents a 25.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.27% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
Several brokerages have issued reports on XYL. Wall Street Zen lowered shares of Xylem from a “buy” rating to a “hold” rating in a research note on Saturday, December 27th. Barclays lowered their price target on Xylem from $172.00 to $166.00 and set an “overweight” rating on the stock in a research report on Wednesday, January 7th. Royal Bank Of Canada raised their target price on shares of Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a research note on Wednesday, October 29th. Stifel Nicolaus increased their price target on shares of Xylem from $175.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, October 29th. Finally, Mizuho dropped their target price on shares of Xylem from $160.00 to $150.00 and set a “neutral” rating on the stock in a report on Monday, January 5th. Nine analysts have rated the stock with a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $165.80.
View Our Latest Report on Xylem
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
See Also
- Five stocks we like better than Xylem
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- NEW LAW: Congress Approves Setup For Digital Dollar?
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Executive Order 14330: Trump’s Biggest Yet
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
